Cargando…
Dual effects of constitutively active androgen receptor and full-length androgen receptor for N-cadherin regulation in prostate cancer
Constitutively active androgen receptor (AR) variants have been involved in the expression of mesenchymal markers such as N-cadherin in prostate cancer (PCa). However, the underlying molecular mechanisms remain elusive. It remains unclear, whether N-cadherin gene (CDH2) is a direct transcriptional t...
Autores principales: | Cottard, Félicie, Madi-Berthélémy, Pauline Ould, Erdmann, Eva, Schaff-Wendling, Frédérique, Keime, Céline, Ye, Tao, Kurtz, Jean-Emmanuel, Céraline, Jocelyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641107/ https://www.ncbi.nlm.nih.gov/pubmed/29069764 http://dx.doi.org/10.18632/oncotarget.18270 |
Ejemplares similares
-
Androgen receptor‐mediated transcriptional repression targets cell plasticity in prostate cancer
por: Erdmann, Éva, et al.
Publicado: (2022) -
Constitutively Active Androgen Receptor Variants Upregulate Expression of Mesenchymal Markers in Prostate Cancer Cells
por: Cottard, Félicie, et al.
Publicado: (2013) -
Constitutively Active Androgen Receptor in Hepatocellular Carcinoma
por: Montgomery, Emma J., et al.
Publicado: (2022) -
Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy
por: Cao, Bo, et al.
Publicado: (2014) -
Androgen regulation of the androgen receptor coregulators
por: Urbanucci, Alfonso, et al.
Publicado: (2008)